A Closer Look at Great-West Lifeco (TSX:GWO) Valuation After Strong Share Price Gains

Great-West Lifeco (TSX:GWO) has been on investors’ radar lately as its stock has delivered strong returns over the past month and year, outpacing many peers in the insurance sector. Despite a lack of a specific news event, the stock’s momentum invites a closer look at what is driving these gains and whether current trends are sustainable.

See our latest analysis for Great-West Lifeco.

The recent rise in Great-West Lifeco’s share price, now at $62.96, has certainly turned heads. Momentum has been building, with an impressive 30-day share price return of 8.8%, helping drive a 34.1% gain so far this year. Looking over a longer period, the company has delivered a striking total shareholder return of 129% over three years and 163% over five, reinforcing its reputation for steady compounding. This kind of performance points to improving growth prospects and growing investor confidence in Great-West Lifeco’s strategic direction.

If you’re curious about what other stocks have been gaining momentum, it might be the right moment to broaden your search and discover fast growing stocks with high insider ownership

With shares riding high after considerable gains, the real question is whether Great-West Lifeco is still trading at an attractive valuation or if the market has already priced in all of its future growth potential.

Most Popular Narrative: 0.2% Undervalued

Great-West Lifeco’s last close of CA$62.96 sits almost precisely at the narrative's fair value estimate of CA$63.08 per share, a rare alignment. This close match has sparked debate over whether forward profit growth justifies current pricing or conceals further upside.

"Expansion of fee-based, capital-light wealth and asset management businesses (such as Empower) provides more stable, recurring earnings and higher return on equity, leading to more predictable and higher-quality earnings growth. Significant runway for revenue growth exists from capturing money in motion through rollovers/crossovers and increased product penetration among Empower's large participant base, which is likely to boost both asset-based and participant-based fee income."

Read the complete narrative.

Curious what bold financial projections are built into this razor-thin discount? The narrative hides key assumptions on revenue expansion and profit improvement that could tip the scales. Would knowing the future profit and revenue leaps driving this almost-perfect pricing signal change your outlook? Click through for the full story behind the number.

Result: Fair Value of $63.08 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, persistent fee compression and execution risks in digital initiatives could still disrupt Great-West Lifeco’s projected growth and challenge optimistic forecasts going forward.

Find out about the key risks to this Great-West Lifeco narrative.

Build Your Own Great-West Lifeco Narrative

If you want to look at the numbers yourself, test your own assumptions, or take a different approach, it's easy to craft your perspective in just a few minutes. Do it your way

A good starting point is our analysis highlighting 4 key rewards investors are optimistic about regarding Great-West Lifeco.

Ready for Your Next Smart Move?

Smart investors know that opportunity does not wait. Broaden your portfolio by taking advantage of expertly curated ideas you might otherwise miss out on right now.

• Maximize yield potential by targeting these 15 dividend stocks with yields > 3%, offering market-beating income with solid fundamentals and sustainable payouts.
• Tap into the future of medicine by evaluating these 30 healthcare AI stocks, helping shape innovation and breakthroughs within the healthcare sector.
• Capture unrecognized value early by reviewing these 898 undervalued stocks based on cash flows, where significant upside could be waiting for sharp-eyed investors.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com